Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between natural killer cells and regression in melanocytic lesions
Kristopher McKay, Page C. Moore, Bruce R. Smoller, et al.
Human Pathology (2011) Vol. 42, Iss. 12, pp. 1960-1964
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu, Jonathan J. Hodgins, Malvika Marathe, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 10, pp. 4654-4668
Open Access | Times Cited: 664
The paradoxical role of IL-10 in immunity and cancer
Mark H. Mannino, Ziwen Zhu, Huaping Xiao, et al.
Cancer Letters (2015) Vol. 367, Iss. 2, pp. 103-107
Closed Access | Times Cited: 424
Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer
Christine L. Pasero, Gwénaëlle Gravis, Samuel Granjeaud, et al.
Oncotarget (2015) Vol. 6, Iss. 16, pp. 14360-14373
Open Access | Times Cited: 184
Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma
Andrea Ladányi
Pigment Cell & Melanoma Research (2015) Vol. 28, Iss. 5, pp. 490-500
Open Access | Times Cited: 154
NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
Alexandra Frazao, Louise Rethacker, Meriem Messaoudene, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 80
Modulation of innate immunity in the tumor microenvironment
Elena González-Gugel, Mansi Saxena, Nina Bhardwaj
Cancer Immunology Immunotherapy (2016) Vol. 65, Iss. 10, pp. 1261-1268
Open Access | Times Cited: 66
CD56dim CD16− Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α
Lazar Vujanović, Christopher A Chuckran, Yan Lin, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 58
MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It
Elena Shklovskaya, Helen Rizos
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6741-6741
Open Access | Times Cited: 42
Phenotypic and Functional Characteristics of Blood Natural Killer Cells from Melanoma Patients at Different Clinical Stages
Giulia Fregni, Meriem Messaoudene, Emmanuelle Fourmentraux-Neves, et al.
PLoS ONE (2013) Vol. 8, Iss. 10, pp. e76928-e76928
Open Access | Times Cited: 62
Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy
Raquel Tarazona, Esther Durán, Rafael Solana
Frontiers in Immunology (2016) Vol. 6
Open Access | Times Cited: 47
Natural Killer Cells as Helper Cells in Dendritic Cell Cancer Vaccines
M. Betina Pampena, Estrella Mariel Levy
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 44
Spontaneous regression of malignant melanoma - is it based on the interplay between host immune system and melanoma antigens?
Monika Červinková, Petra Kučerová, Jana Čížková
Anti-Cancer Drugs (2017) Vol. 28, Iss. 8, pp. 819-830
Closed Access | Times Cited: 43
NK cells sense tumors, course of disease and treatments
Giulia Fregni, Aurélie Perier, Marie‐Françoise Avril, et al.
OncoImmunology (2012) Vol. 1, Iss. 1, pp. 38-47
Open Access | Times Cited: 39
Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer
Dandan Bao, Chenghao Zhang, Longlong Li, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 25
NK Cells in the Tumor Microenvironment as New Potential Players Mediating Chemotherapy Effects in Metastatic Melanoma
Cinzia Garofalo, Carmela De Marco, Costanza Maria Cristiani
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24
Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce a “Hot” Tumor Microenvironment That Is Responsive to Immunotherapy
Robin Reschke, Daniel J. Olson
Cancers (2022) Vol. 14, Iss. 10, pp. 2458-2458
Open Access | Times Cited: 18
Vasculogenic mimicry structures in melanoma support the recruitment of monocytes
Lih Y. Tan, Michaelia P. Cockshell, Eli Moore, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 17
Melanoma: oncogenic drivers and the immune system.
Niki Karachaliou, Sara Pilotto, Cristina Teixidó, et al.
PubMed (2015) Vol. 3, Iss. 18, pp. 265-265
Closed Access | Times Cited: 30
Non-canonical PD-1 signaling in cancer and its potential implications in clinic
Haoran Zha, Ying Jiang, Xi Wang, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 2, pp. e001230-e001230
Open Access | Times Cited: 20
Innate immunity in cutaneous melanoma
Chiara Mignogna, Elisabetta Scali, Caterina Camastra, et al.
Clinical and Experimental Dermatology (2017) Vol. 42, Iss. 3, pp. 243-250
Closed Access | Times Cited: 28
Immune alterations in malignant melanoma and current immunotherapy concepts
Alexei Shimanovsky, Ashif Jethava, Constantin A Dasanu
Expert Opinion on Biological Therapy (2013) Vol. 13, Iss. 10, pp. 1413-1427
Closed Access | Times Cited: 23
Exploiting natural killer cells for therapy of melanoma
Oliver Hölsken, Matthias Miller, Adelheid Cerwenka
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2015) Vol. 13, Iss. 1, pp. 23-28
Open Access | Times Cited: 21
HO‐1 downregulation favors BRAFV600melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition
Anna Lisa Furfaro, Selene Ottonello, Giulia Loi, et al.
International Journal of Cancer (2019) Vol. 146, Iss. 7, pp. 1950-1962
Open Access | Times Cited: 21
Intratumoral versus Circulating Lymphoid Cells as Predictive Biomarkers in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Is the Easiest Path the Best One?
Marta Gascón Ruiz, Dolores Isla, Mara Cruellas, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1525-1525
Open Access | Times Cited: 18
Low baseline levels of NK cells may predict a positive response to ipilimumab in melanoma therapy
Julia K. Tietze, Daniela Angelova, Markus V. Heppt, et al.
Experimental Dermatology (2016) Vol. 26, Iss. 7, pp. 622-629
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top